Halozyme to participate in the td cowen 45th annual healthcare conference

San diego , feb. 26, 2025 /prnewswire/ -- halozyme therapeutics, inc. (nasdaq: halo) ("halozyme") today announced that dr. helen torley, president and chief executive officer, will present and host investor meetings at the td cowen 45th annual healthcare conference. the presentation is scheduled for wednesday, march 5 at 8:50am pt / 11:50am et.
COWN Ratings Summary
COWN Quant Ranking